The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNEX.L Regulatory News (NEX)

  • There is currently no data for NEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Mar 2023 14:11

RNS Number : 5078U
National Express Group PLC
28 March 2023
 

 

NATIONAL EXPRESS GROUP PLC

 ("Company")

 

Director/PDMR Share Dealing

 

The Company provides notification of the following transactions, effected on 27 March 2023, relating to the below named Persons Discharging Managerial Responsibilities ("PDMRs") and their respective interests in the ordinary shares of nominal value 5p each in the capital of the Company ("Shares") (ISIN: GB0006215205).

 

The transactions arise in respect of: (i) the awards of forfeitable Shares made to each of Ignacio Garat and James Stamp under the rules of the Company's Executive Deferred Bonus Plan ("EDBP") in accordance with the Directors Remuneration Policy (the "Policy") (the "2023 EDBP Award"), and (ii) the grant under the rules of the Company's Long-Term Incentive Plan ("LTIP") to each of Ignacio Garat, James Stamp and Simon Callander of three-year performance conditioned nil-cost options over Shares (the "2023 LTIP Award"), the grant of the 2023 LTIP Award to Ignacio Garat and James Stamp also being in accordance with the Policy.

 

In agreeing the terms applicable to the 2023 LTIP Award, the Remuneration Committee of the Board had determined that in the event that the Company's share price at the time of grant was less than 185p (a 23% reduction on the price at the time of the 2022 LTIP grant) the Committee would scale back grants to recipients of those awards. At the time of grant, the Company's share price (according to the middle market quotation of the Company's share price on the last dealing day prior to the date of grant of the awards) was 117.5p. Accordingly in line with the Remuneration Committee's decision to scale back grants in those circumstances, a reduction of 30% has been applied to each of the 2023 LTIP Awards which are the subject of this notification. The numbers shown below in relation to the 2023 LTIP Award are post that reduction. 

 

Additionally, the Remuneration Committee retains discretion to adjust the outcome of the vesting of the 2023 LTIP Awards having regard to all relevant circumstances, including the Company's performance and the Company's shareholders' experience, over the three-year performance period and further to adjust the vesting of the Awards downwards if that vesting would otherwise result in a windfall gain.

 

Individual PDMR and transaction details are set out in the table below:

 

Name and position of PDMR

Number of forfeitable Shares awarded under the 2023 EDBP Award¹

Number of Shares over which the 2023 LTIP Award was granted2

Unrestricted beneficial interest held in Shares following the transactions3

 

Total other

interest held in

Shares following the transactions4

 

Ignacio Garat, Group Chief Executive Officer

 

 

252,093 shares

 

714,894 shares

 

 

107,204

 

1,812,299

 

James Stamp, Group Chief Financial Officer

 

 

31,595 shares

 

379,787 shares

 

 

17,223

 

781,868

 

Simon Callander, Group General Counsel and Company Secretary 

NA

297,574 shares

 

 

50,000

505,352

¹ The number of forfeitable Shares awarded to Mr Garat and Mr Stamp was determined based on a share price of 118.0 pence, being the average mid-market price of a Company share for the five business days immediately preceding the date of award.

² The conversion of the 2023 LTIP Award value into the number of Shares over which it was granted is described above. The 2023 LTIP Awards are shown over the maximum number of Shares which can vest.

³ Including those held by connected persons.

4 Represents outstanding awards granted under the Company's Executive Deferred Bonus Plan and the Company's Long-Term Incentive Plan.

 

1.

Details of PDMR / PCA

Full Name

Ignacio Garat

Position / status

Group Chief Executive Officer, PDMR

Initial notification / amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

 

 

 

Name

National Express Group PLC

LEI

213800A8IQEMY8PA5X34

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument

 

Ordinary shares of 5p each

 

 

 

 

Identification code

GB0006215205

 

Nature of the transaction

(i)Award of forfeitable shares under the National Express Group PLC (the "Company") Executive Deferred Bonus Plan

(ii)Award of option over shares under the Company's Long-Term Incentive Plan

Price(s) and volume(s)

Price(s)

Volume(s)

Total

(i)

£ n/a

252,093

0.00

(ii)

£ n/a

714,894

0.00

Date of the transaction

27 March 2023

Place of the transaction

n/a

 

 

 

1.

Details of PDMR / PCA

Full Name

James Stamp

Position / status

Group Chief Financial Officer, PDMR

Initial notification / amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

 

 

 

Name

National Express Group PLC

 

LEI

213800A8IQEMY8PA5X34

 

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the financial instrument

 

Ordinary shares of 5p each

 

 

 

 

 

Identification code

GB0006215205

 

 

Nature of the transaction

(i) Award of forfeitable shares under the National Express Group PLC (the "Company") Executive Deferred Bonus Plan

(ii) Award of option over shares under the Company's Long-Term Incentive Plan

 

Price(s) and volume(s)

Price(s)

Volume(s)

Total

(i)

£ n/a

31,595

0.00

(ii)

£ n/a

379,787

0.00

 

Date of the transaction

27 March 2023

 

Place of the transaction

n/a

 

 

1.

Details of PDMR / PCA

Full Name

Simon Callander

Position / status

Group General Counsel & Company Secretary, PDMR

Initial notification / amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

 

 

 

Name

National Express Group PLC

 

LEI

213800A8IQEMY8PA5X34

 

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the financial instrument

 

Ordinary shares of 5p each

 

 

 

 

 

Identification code

GB0006215205

 

 

Nature of the transaction

Award of option over shares under the National Express Group PLC Long-Term Incentive Plan

 

Price(s) and volume(s)

Price(s)

Volume(s)

Total

£ n/a

297,574

0.00

 

Date of the transaction

27 March 2023

 

Place of the transaction

n/a

 

 

 

This above notice is given in fulfilment of the Company's obligation under DTR 3.1 and Article 19 of the EU Market Abuse Regulation 596/2014.

 

- END -

 

 

National Express contact and telephone number for enquiries:

 

Simon Callander, Group General Counsel & Company Secretary

+44 (0) 7795 232 708

 

Gillian Saunderson, Deputy Company Secretary

+44 (0) 7506 642 348

 

Notes:

Legal Entity Identifier: 213800A8IQEMY8PA5X34

Classification: 3.1 (with reference to DTR6 Annex 1R)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKFBKNBKDQNB
Date   Source Headline
20th Jun 202311:21 amRNSChange of Name
16th Jun 20232:51 pmRNSHolding(s) in Company
14th Jun 20239:02 amRNSHolding(s) in Company
2nd Jun 20237:00 amRNSDirector/PDMR Shareholding
10th May 20234:11 pmRNSResult of AGM
10th May 20237:00 amRNSChange of Name
19th Apr 20237:00 amRNSQ1 Trading Update
14th Apr 202312:43 pmRNSHolding(s) in Company
3rd Apr 20239:16 amRNSTotal Voting Rights
30th Mar 20233:54 pmRNSHolding(s) in Company
30th Mar 20231:21 pmRNSHolding(s) in Company
30th Mar 20231:17 pmRNSHolding(s) in Company
28th Mar 20234:33 pmRNSHolding(s) in Company
28th Mar 20232:11 pmRNSDirector/PDMR Shareholding
27th Mar 20235:34 pmRNSHolding(s) in Company
27th Mar 202310:12 amRNS2022 Annual Report and Notice of 2023 AGM
20th Mar 20234:52 pmRNSHolding(s) in Company
17th Mar 20234:32 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
9th Feb 20237:00 amRNSNotice of FY22 Results Presentation
23rd Jan 20237:00 amRNSEUR1 Billion German Rail Contract Award
3rd Jan 202311:02 amRNSTotal Voting Rights
5th Dec 20227:00 amRNSAPPOINTMENT OF GROUP CFO
20th Oct 20227:00 amRNSTrading Statement
3rd Oct 20229:15 amRNSDirector/PDMR Shareholding
3rd Oct 20229:11 amRNSTotal Voting Rights
8th Sep 20227:01 amRNSAPPOINTMENT OF INTERIM GROUP CFO
8th Sep 20227:00 amRNSAPPOINTMENT OF CHAIR DESIGNATE
5th Sep 20224:22 pmRNSDirector/PDMR Shareholding
15th Aug 202212:54 pmRNSDirector/PDMR Shareholding
10th Aug 20227:04 amRNSDirectorate Change
4th Aug 20223:27 pmRNSHolding(s) in Company
1st Aug 202211:32 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSHalf-year Report
1st Jul 20228:31 amRNSTotal Voting Rights
28th Jun 20221:01 pmRNSHolding(s) in Company
23rd Jun 202210:23 amRNSDirector/PDMR Shareholding
13th Jun 20221:43 pmRNSPublication of a Prospectus
10th Jun 20223:43 pmRNSDirector/PDMR Shareholding
9th Jun 20223:16 pmRNSHolding(s) in Company
7th Jun 20227:00 amRNSTrading Statement
24th May 20221:56 pmRNSForm 8.3 - Stagecoach Group plc
24th May 20221:48 pmRNSForm 8.3 - National Express Group plc
23rd May 20223:52 pmRNSForm 8.3 - STAGECOACH GROUP PLC
23rd May 20223:49 pmRNSForm 8.3 - National Express Group plc
23rd May 20223:31 pmRNSForm 8.3 -National Express Group plc
23rd May 20223:20 pmRNSForm 8.3 - National Express Group plc
23rd May 20221:51 pmGNWForm 8.3 - National Express Group PLC
23rd May 20221:29 pmRNSForm 8.3 - National Express Group Plc
23rd May 202211:35 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - National Express Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.